kt-333
T-cell Prolymphocytic Leukemia (T-PLL)
Kymera Therapeutics, Inc.Phase 1
—
Rating in progress
kt-333 in T-cell Prolymphocytic Leukemia (T-PLL) is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active